William A. Wexler insider trades

Open-market stock purchases and sales by William A. Wexler, Director at Eterna Therapeutics Inc, from SEC Form 4 filings since Aug 1, 2022.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • ERNA Eterna Therapeutics Inc: other filings, last Feb 7, 2025
  • CMRA Comera Life Sciences Holdings, Inc: other filings, last Nov 15, 2023
  • BTX Brooklyn ImmunoTherapeutics, Inc: other filings, last Aug 1, 2022

Get free alerts when William A. Wexler files a new trade →